A Multicenter, Single Arm, Phase Ib/II Study to Evaluate Efficacy, Safety, and PK of MSC2156119J as Monotherapy in Subjects With MET+ Advanced Hepatocellular Carcinoma With Child Pugh Class A Liver Function Who Have Failed Sorafenib Treatment
收藏DataCite Commons2026-04-29 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00013046/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This is a Phase 1b/2, multicenter, single arm trial to assess the efficacy, safety, and pharmacokinetics (PK) of MSC2156119J as monotherapy in subjects with MET+ advanced hepatocellular carcinoma (HCC) with child Pugh Class A liver function who have failed sorafenib treatment.
提供机构：
Vivli
创建时间：
2026-04-29
